BGMA urges government to ‘resist’ any US moves to change drug patents
The government must hold out against changes to drug patents and exclusivity provisions to protect the NHS and save money, BGMA director general Warwick Smith has said.
The government must hold out against changes to drug patents and exclusivity provisions to protect the NHS and save money, BGMA director general Warwick Smith has said.